Hanmi Science Co., Ltd. logo

Hanmi Science Co., Ltd. (008930)

Market Closed
12 Jun, 06:30
KRX SM KRX SM
30,100. 00
+300
+1.0067%
2.62T Market Cap
- P/E Ratio
300% Div Yield
73,620 Volume
- Eps
29,800
Previous Close
Add Transaction
Day Range
29,900 31,000
Year Range
28,100 55,500
Want to track 008930 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

008930 closed today higher at ₩30,100, an increase of 1.0067% from yesterday's close, completing a monthly decrease of -20.9974% or -₩8,000. Over the past 12 months, 008930 stock lost -16.8508%.
008930 is not paying dividends to its shareholders.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Hanmi Science Co., Ltd. has completed 22 stock splits, with the recent split occurring on Dec 28, 2022.
The company's stock is traded on one exchange.

008930 Chart

People also search for

KT&G Corp.
187,800
+1.4587%
Samyang Foods Co., Ltd.
1,145,000
-2.6361%
Amorepacific Corp.
112,000
+0.1789%
Amorepacific Corp. Preferred Stock
35,800
+1.4164%
LG H&H Preferred Stock
105,000
+3.9604%

Hanmi Science Co., Ltd. (008930) FAQ

What is the stock price today?

The current price is ₩30,100.00.

On which exchange is it traded?

Hanmi Science Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 008930.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 300%.

What is its market cap?

As of today, the market cap is 2.62T.

Has Hanmi Science Co., Ltd. ever had a stock split?

Hanmi Science Co., Ltd. had 22 splits and the recent split was on Dec 28, 2022.

Hanmi Science Co., Ltd. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Mr. Jong-Hoon Lim CEO
KRX SM Exchange
KR7008930000 ISIN
KR Country
475 Employees
30 Mar 2026 Last Dividend
27 Dec 2018 Last Split
- IPO Date

Overview

Hanmi Science Co., Ltd., with its operational base in Seoul, South Korea, has been a notable figure in the pharmaceutical industry since its inception in 1973. Originally named Hanmi Holdings Co., Ltd., the company underwent a rebranding in March 2012 to emerge as Hanmi Science Co., Ltd. It operates on a global scale, providing a plethora of pharmaceutical products not just within Korea but also to an international clientele. The company's comprehensive reach spans from the development, manufacture, to the sale of varied pharmaceutical solutions. It leverages both online and offline channels, including pharmacies, to distribute its products, underscoring its robust presence in the pharmaceutical market.

Products and Services

  • Diabetes and Anti-Cancer Drugs
  • At the heart of Hanmi Science's product line are its innovative offerings for managing diabetes and combating cancer. These critical therapeutic categories benefit from the company's continuous commitment to research and development, aiming to bring forward novel and effective treatment options.

  • Bowel Preparation and Cold Medicines for Children and Adults
  • Understanding the need for specialized medications across age groups, Hanmi Science produces a range of drugs for bowel preparation, aligning with procedural prerequisites, alongside cold medicines. These products are formulated to cater to both pediatric and adult patients, ensuring broad demographic applicability.

  • Cephalosporin Antibiotics
  • A staple in the fight against bacterial infections, cephalosporin antibiotics represent a crucial part of Hanmi Science's pharmaceutical repertoire. The company's antibiotics are pivotal in addressing various bacterial conditions, emphasizing its role in infectious disease management.

  • General Foods, Health Functional Foods, and Soy Milk
  • Expanding beyond pharmaceuticals, Hanmi Science also ventures into nutrition and wellness through its general and health functional foods, including soy milk. These products underscore the company's holistic approach to health, catering to the nutritional needs and well-being of its customers.

  • Medical Equipment
  • The manufacture and distribution of medical equipment further diversify Hanmi Science's offerings. This segment includes innovative solutions that support the healthcare industry, embodying the company's commitment to enhancing medical care quality and accessibility.

  • Automated Drug Management Systems
  • Embracing technological advancement, Hanmi Science offers automated drug management systems. These systems streamline pharmaceutical logistics and inventory management for healthcare providers, showcasing Hanmi Science's dedication to improving operational efficiency and patient care through innovation.

Contact Information

Address: 14 Wiryeseong-daero, Seoul, South Korea, 05545
Phone: 82 2 410 9114